Solomon Moshkevich $NTRA SEC Form 4 Insider Trading

Solomon Moshkevich has filed a total of 107 insider trades in $NTRA since 2021. Their most recent trade was a sale of 213 shares, made on Jun 01, 2026. Their largest trade was a sale of 53,489 shares, made on Apr 16, 2024. We estimate that they now own 138,841 shares of $NTRA, worth an estimated $29.4 million.

Insider Trading at $NTRA

There have been a total of 1221 insider trades reported at $NTRA since 2021, with 375,220 shares purchased and 4.9 million shares sold. The most active insider traders in $NTRA stock have been Steven Leonard Chapman, Michael Burkes Brophy, and Solomon Moshkevich. The most recent trade was a sale of 413 shares reported by Solomon Moshkevich (PRESIDENT, CLINICALDIAGNOSTICS), made on Jun 01, 2026.

$NTRA Executives and Stock Owners with Insider Trades

• Steven Leonard Chapman, CEO AND PRESIDENT

• Michael Burkes Brophy, CHIEF FINANCIAL OFFICER

• Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS

• Daniel Rabinowitz, SEC. AND CHIEF LEGAL OFFICER

• Matthew Rabinowitz, EXECUTIVE CHAIRMAN

• John Fesko, PRESIDENT, CHIEF BUS. OFFICER

• Robert Alan Schueren, CHIEF OPERATING OFFICER

• Daniel Rabinowitz, CHIEF LEGAL OFFICER

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.